Bolt Biotherapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
BOLT on Nasdaq
Location
900 Chesapeake Drive, Redwood City, CA

Insiders trading volume in the past year

Bolt Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vivo Capital VIII, LLC 10%+ Owner $5.44M Nov 21, 2023
Novo Holdings A/S 10%+ Owner $3.52M Jul 13, 2022
Edgar Engleman Director $1.97M Nov 29, 2023
Edith A. Perez Chief Medical Officer $36.5K Mar 4, 2024
William P. Quinn President, CEO and CFO, Director $24.7K +$1.24K +5.29% May 1, 2025
Randall C. Schatzman Chief Executive Officer, Director $10.1K Mar 4, 2024
Sarah Nemec Senior VP, Finance and PAO $8.84K +$1.24K +16.3% May 1, 2025
Kathleen Laporte Director May 27, 2025
Grant Yonehiro Chief Operating Officer May 1, 2025
Brian O'callaghan Director May 27, 2025
Frank D. Lee Director Jun 12, 2024
Mahendra Shah Director Jun 12, 2024
Jakob Dupont Director May 27, 2025
David Dornan Chief Scientific Officer Feb 18, 2022
Laura Berner Director May 27, 2025
Richard A. Miller Director Jun 12, 2023
Nicole Onetto Director May 27, 2025
James Healy Director Jun 12, 2024

Recent Insider Transactions by Companies or Individuals for Bolt Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.